Award celebrates success within the quoted smaller companies arena Jonathan Milner, the CEO and principal founder of Abcam, was awarded ‘CEO of the Year’ at the Grant Thornton Quoted Company Awards. The awards recognize the achievements of smaller quoted companies below the FTSE 350 through to AIM and PLUS, and the ceremony was held at […]
AIM stock exchange celebrates Abcam’s strength of business and potential for growth Abcam picked up the top prize at the 2009 AIM Awards, winning ‘Company of the Year’. The award, described as the ‘ultimate accolade’ for any company on the AIM market, was announced at the AIM Awards Dinner in London in October 15. It […]
New headquarters underlines Abcam’s optimism for the future In June, Abcam opened its new global headquarters at 330 Cambridge Science Park, Cambridge, UK marking the latest step in the company’s expansion. The new headquarters, at 25,000 sq ft, is double the size of the previous building, which was located just 200 m away. The additional […]
Three lucky labs celebrate Abcam’s tenth anniversary Dr Fumiko, (Pathology Institute, Tokyo), Dr Koh (Johns Hopkins University) and Dr Smit-Rigter (University of Amsterdam) were announced as the winners of our birthday competition. Read the full Abcam story.
Two year agreement supports Abcam’s range of kits and other non-antibody products Over 500 kits now available Abcam has extended its global licensing agreement with Tepnel Life Sciences. The two year deal means that Abcam will continue to distribute Tepnel’s Diaclone range of products to scientists worldwide. The agreement supports Abcam’s growing range of non-antibody products, […]
Events held at the British embassy on Feb 22nd and British Consulate-General on Mar 5th Sales teams from our seven new Japanese sub-dealers found themselves invited to prestigious venues courtesy of Abcam. Two events were held, one at the British embassy in Tokyo, and one at the British consulate-general in Osaka, to give the sub-dealers […]
Abcam and Beckman Coulter have announced a major bioscience collaboration – to create one of the world’s most sophisticated, automated systems for the production of monoclonal antibodies for use in research. The move is part of the development of Abcam’s new, multi-million pound laboratory which will provide high throughput monoclonal antibody generation, purification and characterization. […]
As part of its efforts to continue developing the largest online catalogue of the best antibodies in the world, Abcam has entered into an collaborative agreement with a leading antibody producer to make around 12,000 rabbit polyclonals over the next two years. The agreement builds on an existing partnership deal with this antibody producer to […]
Registered Office:
Discovery Drive, Cambridge
Biomedical Campus,
Cambridge, CB2 0AX, UK
+44 (0) 1223 696 000
© Abcam Limited. all rights reserved.
Abcam Limited is incorporated in England and Wales, its main country of operation in the UK. Use of this website is subject to our Terms and Conditions of use and our Privacy Policy. Share price and news information on this site is updated dynamically from external data feeds.
Website by FisherPaul